The Arg389Gly β1-adrenergic receptor gene polymorphism and susceptibility to faint during head-up tilt test

Europace

Volumn 9, Issue 8, 2007, Pages 585-588

  Marquez M F ^a   Hernández Pacheco, Guadalupe ^a   Hermosillo, Antonio G ^a   Gómez, Jorge R ^a   Cárdenas, Manuel ^a   Vargas Alarcón, Gilberto ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Adrenergic receptors; Autonomic nervous system; Genetics; Vasovagal syncope

Indexed keywords

ARGININE; BETA 1 ADRENERGIC RECEPTOR; GENOMIC DNA; GLYCINE; NITRATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; LINKAGE ANALYSIS; MALE; MEXICO; MUTATIONAL ANALYSIS; ORTHOSTATIC STRESS; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYNCOPE; TILT TABLE TEST; GENETIC PREDISPOSITION; GENETICS; MUTATION; STATISTICS;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; MEXICO; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-1; SYNCOPE; TILT-TABLE TEST;

EID: 34547927626     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum059     Document Type: Article

References (23)

1. Soteriades E, Evans J, Larson M, Chen M, Chen L, Benjamin E et al. Incidence and prognosis of syncope. N Engl J Med 2002;347 878-85.
2. Benditt DG. Syncope. In: Podrid PJ, Kowey PR. Cardiac Arrhythmia. Mechanism, Diagnosis and Management. 2nd ed. Lippincott Williams and Wilkins Co: Philadelphia; 2001. pp 931.
3. La Rosée K, Huntgeburth M, Rosenkranz S, Böhm M, Schnabel P. The Arg389Gly β1-adrenoceptor gene polymorphism determines contractile response to catecholamines. Pharmacogenetics 2004;14:711-6.
4. Lahiri DK, Nurnberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucl Acids Res 1991;19:5444.
5. Maqbool A, Hall AS, Ball SG, Balmforth AJ. Common polymorphisms of β1-adrenoceptor: Identification and rapid screening assay. Lancet 1999;353:897.
6. Woolf B. On estimating the relation between blood groups and disease. Ann Hum Genet 1955;19:251-3.
7. Fragoso JM, Rodríguez-Pérez JM, Pérez-Vielma N, Martínez- Rodríguez N, Vargas-Alarcón G. β1 adrenergic receptor polymorphisms Arg389Gly and Ser49Gly in the Amerindians and Mestizo populations of Mexico. Hum Biol 2005;77:515-20.
8. Mason DA, Moore JD, Green SA, Liggett SB. A gain of fuction polymorphism in a G-protein coupling domain of the human β1-adrenergic receptor. J Biol Chem 1999;274:12670-4.
9. 1-adrenoceptor polymorphism varies in frequency among differen ethnic groups but does not alter response in vivo. Pharmacogenetics 2001;11:191-7.
10. Frielle T, Collins S, Daniel KW, Caron MG, Lefkowitz RJ, Kobilka BK. Cloning of the cDNA for the human β1-adrenergic receptor. Proc Natl Acad Sci USA 1987;84:7920-4.
11. Méndez R, Kabela E. Cardiac pharmacology. Ann Rev Pharmacol 1970;10:291-312.
12. Márquez MF, Urías KI, Hermosillo AG, Jardón JL, Iturralde P, Colín L et al. Familial vasovagal syncope. Europace 2005;7:472-4.
13. Newton JL, Kerr S, Pairman J, McLaren A, Norton M, Kenny RA et al. Familial neurocardiogenic (vasovagal) syncope. Am J Med Genet 2005;133A:176-9.
14. Grubb BP. Evaluation and management of syncope. In: Ganz LI, ed. Management of Cardiac Arrhythmias. Totowa, NJ: Humana; 2002. p 183-207.
15. Wagoner LE, Craft LL, Zenget P, McGuire N, Rathz DA, Dorn GW et al. Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure. Am Heart J 2002;144:840-6.
16. Iwai C, Akita H, Shiga N, Takai E, Miyamoto Y, Shimizu M et al. Suppressive effect of the Gly389 allete of the beta1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy. Circ J 2002;66:723-8.
17. Forteo C, Resta N, Sorrentino S, Guida P, Manghisi A, De Luca V et al. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy. Am J Med 2004;117:451-8.
18. Magnusson Y, Levin MC, Eggertsen R, Nystrom E, Mobini R, Schaufelberger M et al. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy. Clin Pharmacol Ther 2005;78:221-31.
19. Sandilands AJ, O'Shaughnessy KM, Brown MJ. Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta 1-adrenoceptors versus Gly389 beta 1-adrenoceptors in isolated human atrial myocardium. Br J Pharmacol 2003;138:386-92.
20. Bengtsson K, Melander O, Orho-Melander M, Lindblad U, Ranstam J, Rastam L et al. Polymorphism in the beta (1)-adrenergic receptor gene and hypertension. Circulation 2001;104:187-90.
21. Bruck H, Leineweber K, Temme T, Weber M, Heusch G, Philipp T et al. The Arg389Gly betal-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity. J Am Coll Cardiol 2005;46 2111-5.
22. Winker R, Barth A, Valic E, Maier R, Osterode W, Pilger A et al. Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance. Int Arch Occup Environ Health 2005;78:171-7.
23. Hermosillo AG, Márquez MF, Jaúregui-Renaud K, Cárdenas M. Orthostatic hypotension, 2001. Cardiol Rev 2001;9:339-47.